- জেনেরিক নাম
- Glibenclamide
- শক্তি
- 5 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Square Pharmaceuticals PLC.
৳ ০.৩৪ ৳ ০.৩৫ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
Dibenol 5 mg Tablet একটি ট্যাবলেট ঔষধ, যার জেনেরিক নাম Glibenclamide এবং শক্তি ৫ mg। দাম: প্রতি ইউনিট ০.৩৫ টাকা। এটি তৈরি করে Square Pharmaceuticals PLC। Dibenol-এর সাথে Glibenclamide-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Glibenclamide-এর ১৪টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। এর চেয়ে কম ইউনিট দামের ব্র্যান্ড আছে ৫টি। সবচেয়ে কম দাম Dicon 5 mg Tablet-এর, প্রতি ইউনিট ৳ ০.২৮।
Dibenol 5 mg Tablet is a medicine from Square Pharmaceuticals PLC that contains glibenclamide, a sulfonylurea used in the treatment of non-insulin dependent diabetes mellitus (NIDDM). It works by stimulating the release of insulin from the pancreas to help lower blood sugar. It is not effective in patients whose pancreas has lost all or nearly all ability to secrete insulin, such as completely pancreatectomized patients or those with juvenile-onset diabetes, who require insulin. The doctor decides the dose and course of treatment.
Dibenol 5 mg Tablet is used in the treatment of non-insulin dependent diabetes mellitus (NIDDM). It is not effective in completely pancreatectomized patients or in juvenile-onset type of diabetes, where the pancreas has lost all or nearly all capacity to secrete insulin; such patients require insulin. The doctor will determine if this medicine is suitable for you.
The doctor decides the dose and course of Dibenol 5 mg Tablet. The tablet is usually taken during or immediately after breakfast, but follow your doctor's instructions. Blood sugar and urine sugar levels should be checked as advised by your doctor. Do not change the dose or stop taking the medicine without consulting your doctor. If you miss a dose, ask your doctor or pharmacist for advice.
Dibenol 5 mg Tablet is generally well tolerated. Side effects that may occur include nausea, vomiting, epigastric pain, dizziness, weakness, paraesthesia, and headache. Allergic skin reactions and blood-related reactions such as leukopenia and thrombocytopenia are occasionally observed. If you experience any side effects, contact your doctor. Seek medical help if you have signs of low blood sugar or severe reactions.
Weight reduction is important in the treatment of diabetes and should be part of your overall management. Dibenol 5 mg Tablet is contraindicated in severe metabolic decompensation with acidosis, pre-comatose states, diabetic coma, severe renal or hepatic dysfunction, serious impairment of thyroid or adrenal function, pregnancy, and diabetes complicated by fever, trauma, or gangrene. It should not be used in completely pancreatectomized patients or juvenile-onset diabetes. Discuss with your doctor if you are pregnant, breastfeeding, or have other health conditions.
Dibenol 5 mg Tablet is used for non-insulin dependent diabetes mellitus (NIDDM). It is a sulfonylurea medicine that lowers blood sugar by stimulating insulin release from the pancreas. It is not effective in patients with juvenile-onset diabetes or in those who have had their pancreas removed.
Alcohol, cyclophosphamide, dicoumarol, monoamine oxidase inhibitors, phenylbutazone, propranolol and other beta-blockers, and certain long-acting sulphonamides may increase the blood sugar-lowering effect. Tell your doctor about all medicines you take, including over-the-counter drugs.
Watch for nausea, vomiting, stomach pain, dizziness, weakness, tingling, headache, skin rash, or signs of low blood sugar. Call your doctor if these occur or if you notice unusual bleeding or bruising. Seek immediate help for severe symptoms.
The listed price is ৳ ০.৩৫.
৳ ০.৩৪ ৳ ০.৩৫ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glibenclamide is used in the treatment of non insulin dependent diabetes melitus (NIDDM). It is ineffective in completely pancreatectomized patients and in juvenile-onset type of diabetes, in which the pancreas has lost all or nearly all of its capacity to secrete insulin. Such patients require insulin and attempts to control them with oral therapy are dangerous and doomed to failure.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glibenclamide is an orally effective hypoglycaemic agent that reduces blood sugar concentration by stimulating secretion of endogenous insulin from the pancreatic β-cells. It stimulates the mobilization of endogenous insulin with a lower dosage and with few incidence of side effects that any available anti-diabetic. Hypoglycaemic action associated with short-term therapy appears to include reduction of basal hepatic glucose production and enhancement of peripheral insulin action at target sites.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Initially stabilization dosage: Glibenclamide half tablet (2.5 mg) should be taken initially during or immediately after breakfast. 3-5 days after initiation of the drug, the blood sugar level and urine sugar level should be checked. Daily dose of ½ tablet (2.5 mg) may be continued as maintenance therapy if good control has been achieved. If the result is not good, increment of daily dose in steps of ½ tablet (2.5 mg) is necessary at intervals of 3-5 days up to a maximum of 3 tablets. Daily doses in excess of 10 mg may be taken in 2 divided doses. Patients should be given ½ to 1 tablet of Glibenclamide in changing over from other oral anti-diabetics with a similar action.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Alcohol, cyclophosphamide, dicoumarol, monoamino oxidase inhibitors, phenylbutazone, propranolol and other beta-adrenergic blocking agents and certain long-acting sulphonamides may enhance the hypoglycemic effect of Glibenclamideএই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Severe metabolic de-compensation with acidosis, pre-comatose states and diabetic coma, severe renal or hepatic dysfunction or serious impairment of typhoid or adrenal function; pregnancy, diabetes mellitus complicated by fever, trauma or gangrene.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Glibenclamide is well tolerated. Few side effects that may arise include nausea, vomiting, epigastric pain, dizziness, weakness, paraesthesia and headache. Allergic skin reactions and haemopoietic reactions (leukopenia, thrombocytopenia, etc.) are occasionally observed.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
There is no information on the use of Glibenclamide in human pregnancy but it has been in wide, general use for many years without apparent ill consequence. Animal studies have shown no hazard. It has not yet been established whether Glibenclamide is transferred to human milk. However, other sulphonylureas have been found in milk and there is no evidence to suggest that Glibenclamide differs from the group in this respect.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Weight reduction is of the greatest importance in the treatment of diabetes. A vigorous effort must be made by the patient and the physician to reduce the patient's weight as an integral part of diabetic treatment, irrespective of the drug chosen.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Symptoms: Hypoglycaemia.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Should be stored in a dry place below 30˚ C.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।